Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early vs Delayed Electrochemotherapy for Cutaneous Breast Cancer Metastases
NCT01479946Phase 2Withdrawn
- Sponsor
- Akademiska sjukhuset
- Start
- Oct 2011
- Primary completion
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of bleomycin in breast cancer (2 arms), sponsored by Akademiska sjukhuset. Primary endpoint: local control of skin metastases at 6 months. Planned start Oct 2011; status: withdrawn.
02
Drugs
bleomycin
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01479946.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01479946.